| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |